In-Vitro Anti Diabetic Activity Of Copper (Ii) Complex With Dibenzalacetone

Abstract

Dibenzalacetone ligand was synthesized via Claisen- Schmidt condensation between benzaldehyde and acetone.  The synthesized ligand was characterized by using various spectroscopic techniques such as FT- IR, UV, ¹H, and ¹³C NMR. Further, Dibenzalacetone Copper (II) complex was prepared.  The synthesized complex was characterized by using various spectroscopic techniques  such as FT- IR, UV, ¹H, and ¹³C NMR. Finally, the anti-diabetic activity of Dibenzalacetone Copper (II) complex was assessed using in-vitro assays on amylase and glucoside.  In this work result indicates the promising of the anti-diabetic properties and highlighting the potential of Dibenzalacetone Copper (II) complex for the development on diabetic disease.